+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Clindamycin"

From
From
toxoplasmosis Treatment Drugs Global Market Report 2024 - Product Thumbnail Image

toxoplasmosis Treatment Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Antibiotics Global Market Report 2024 - Product Thumbnail Image

Antibiotics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
Acne Treatment Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Acne Treatment Market - Forecasts from 2024 to 2029

  • Report
  • February 2024
  • 140 Pages
  • Global
From
From
From
From
UAE Antibiotics Market, By Region, By Competition Forecast & Opportunities, 2018-2028F - Product Thumbnail Image

UAE Antibiotics Market, By Region, By Competition Forecast & Opportunities, 2018-2028F

  • Report
  • November 2023
  • 79 Pages
  • United Arab Emirates United Arab Emirates
From
Loading Indicator

Clindamycin is an antibiotic used to treat a variety of bacterial infections, including those caused by anaerobic bacteria. It is commonly used to treat infections caused by Streptococcus, Staphylococcus, and other bacteria. Clindamycin is also used to treat certain types of infections caused by parasites, such as malaria. In the context of infectious diseases drugs, clindamycin is used to treat a wide range of bacterial infections, including those caused by anaerobic bacteria, as well as certain types of infections caused by parasites. It is also used to treat certain types of skin infections, such as acne. The clindamycin market is highly competitive, with a number of companies offering products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Other companies in the market include Allergan, AstraZeneca, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more